National Academies Press: OpenBook
Suggested Citation:"Front Matter." Institute of Medicine. 2008. Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office. Washington, DC: The National Academies Press. doi: 10.17226/12257.
×
Page R1
Suggested Citation:"Front Matter." Institute of Medicine. 2008. Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office. Washington, DC: The National Academies Press. doi: 10.17226/12257.
×
Page R2
Suggested Citation:"Front Matter." Institute of Medicine. 2008. Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office. Washington, DC: The National Academies Press. doi: 10.17226/12257.
×
Page R3
Suggested Citation:"Front Matter." Institute of Medicine. 2008. Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office. Washington, DC: The National Academies Press. doi: 10.17226/12257.
×
Page R4
Suggested Citation:"Front Matter." Institute of Medicine. 2008. Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office. Washington, DC: The National Academies Press. doi: 10.17226/12257.
×
Page R5
Suggested Citation:"Front Matter." Institute of Medicine. 2008. Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office. Washington, DC: The National Academies Press. doi: 10.17226/12257.
×
Page R6
Suggested Citation:"Front Matter." Institute of Medicine. 2008. Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office. Washington, DC: The National Academies Press. doi: 10.17226/12257.
×
Page R7
Page viii Cite
Suggested Citation:"Front Matter." Institute of Medicine. 2008. Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office. Washington, DC: The National Academies Press. doi: 10.17226/12257.
×
Page R8
Suggested Citation:"Front Matter." Institute of Medicine. 2008. Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office. Washington, DC: The National Academies Press. doi: 10.17226/12257.
×
Page R9
Suggested Citation:"Front Matter." Institute of Medicine. 2008. Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office. Washington, DC: The National Academies Press. doi: 10.17226/12257.
×
Page R10

Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Initial Guidance for an Update of the National Vaccine Plan A Letter Report to the National Vaccine Program Office Committee on the Review of Priorities in the National Vaccine Plan Board on Population Health and Public Health Practice

THE NATIONAL ACADEMIES PRESS 500 Fifth Street, N.W. Washington, DC 20001 NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. The members of the committee responsible for the report were chosen for their special competences and with regard for appropriate balance. This study was supported by Contract No. HHSP23320042509XI, TO #15 between the National Academy of Sciences and the Department of Health and Human Services. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the organizations or agencies that provided support for this project. Additional copies of this report are available from the National Academies Press, 500 Fifth Street, N.W., Lockbox 285, Washington, DC 20055; (800) 624-6242 or (202) 334-3313 (in the Washington metropolitan area); Internet, http://www.nap.edu. For more information about the Institute of Medicine, visit the IOM home page at: www.iom.edu. Copyright 2008 by the National Academy of Sciences. All rights reserved. Printed in the United States of America The serpent has been a symbol of long life, healing, and knowledge among almost all cultures and religions since the beginning of recorded history. The serpent adopted as a logotype by the Institute of Medicine is a relief carving from ancient Greece, now held by the Staatliche Museen in Berlin. Suggested citation: IOM (Institute of Medicine). 2008. Initial guidance for an update of the national vaccine plan: A letter report to the national vaccine program office. Washington, DC: The National Academies Press.

The National Academy of Sciences is a private, nonprofit, self-perpetuating society of distinguished scholars engaged in scientific and engineering research, dedicated to the furtherance of science and technology and to their use for the general welfare. Upon the authority of the charter granted to it by the Congress in 1863, the Academy has a mandate that requires it to advise the federal government on scientific and technical matters. Dr. Ralph J. Cicerone is president of the National Academy of Sciences. The National Academy of Engineering was established in 1964, under the charter of the National Academy of Sciences, as a parallel organization of outstanding engineers. It is autonomous in its administration and in the selection of its members, sharing with the National Academy of Sciences the responsibility for advising the federal government. The National Academy of Engineering also sponsors engineering programs aimed at meeting national needs, encourages education and research, and recognizes the superior achievements of engineers. Dr. Charles M. Vest is president of the National Academy of Engineering. The Institute of Medicine was established in 1970 by the National Academy of Sciences to secure the services of eminent members of appropriate professions in the examination of policy matters pertaining to the health of the public. The Institute acts under the responsibility given to the National Academy of Sciences by its congressional charter to be an adviser to the federal government and, upon its own initiative, to identify issues of medical care, research, and education. Dr. Harvey V. Fineberg is president of the Institute of Medicine. The National Research Council was organized by the National Academy of Sciences in 1916 to associate the broad community of science and technology with the Academy’s purposes of furthering knowledge and advising the federal government. Functioning in accordance with general policies determined by the Academy, the Council has become the principal operating agency of both the National Academy of Sciences and the National Academy of Engineering in providing services to the government, the public, and the scientific and engineering communities. The Council is administered jointly by both Academies and the Institute of Medicine. Dr. Ralph J. Cicerone and Dr. Charles M. Vest are chair and vice chair, respectively, of the National Research Council. www.national-academies.org

COMMITTEE ON THE REVIEW OF PRIORITIES IN THE NATIONAL VACCINE PLAN CLAIRE V. BROOME (Chair), Adjunct Professor, Division of Global Health, Rollins School of Public Health, Emory University ÈLAINE CHATIGNY, Director General of Communications, Public Health Agency of Canada TIMOTHY J. HOFF, Associate Professor of Health Policy and Management, Department of Health Policy, Management and Behavior, University at Albany, State University of New York GRACE M. LEE, Assistant Professor of Pediatrics, Children’s Hospital, Harvard University School of Medicine RICHARD MANDSAGER, Executive Director, The Children’s Hospital at Providence, Anchorage, Alaska EDGAR K. MARCUSE, Professor of Pediatrics, Children’s Hospital and Regional Medical Center, University of Washington School of Medicine A. DAVID PALTIEL, Professor and Acting Head, Division of Health Policy and Administration, Yale School of Public Health, Yale University ARTHUR REINGOLD, Professor and Head, Division of Epidemiology, School of Public Health, University of California, Berkeley DAVID B. REUBEN, Chief, Geriatric Medicine, and Director, Multicampus Program in Geriatric Medicine and Gerontology, University of California, Los Angeles SARA ROSENBAUM, Hirsh Professor and Chair, Department of Health Policy, The George Washington University School of Public Health and Health Services MILAGRITOS D. TAPIA, Assistant Professor, Pediatric Infectious Diseases, University of Maryland Study Staff ALINA BACIU, Study Director AMY GELLER, Senior Health Policy Associate LOUISE JORDAN, Senior Project Assistant ROSE MARIE MARTINEZ, Director, Board on Population Health and Public Health Practice v

REVIEWERS This report has been reviewed in draft form by individuals chosen for their diverse perspectives and technical expertise, in accordance with procedures approved by the National Research Council’s Report Review Committee. The purpose of this independent review is to provide candid and critical comments that will assist the institution in making its published report as sound as possible and to ensure that the report meets institutional standards for objectivity, evidence, and responsiveness to the study charge. The review comments and draft manuscript remain confidential to protect the integrity of the deliberative process. We wish to thank the following individuals for their review of this report: Jo Ivey Boufford, New York Academy of Medicine Julie S. Downs, Department of Social and Decision Science, Carnegie Mellon University Barton F. Haynes, Duke Human Vaccine Institute Lisa Jackson, Group Health Center for Health Studies Samuel L. Katz, Department of Pediatrics, Duke University Medical Center Adel A.F. Mahmoud, Woodrow Wilson School and Department of Molecular Biology Princeton University Joshua P. Metlay, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Thomas W. Valente, Department of Preventive Medicine, Keck School of Medicine, University of Southern California Although the reviewers listed above have provided many constructive comments and suggestions, they were not asked to endorse the conclusions or recommendations nor did they see the final draft of the report before its release. The review of this report was overseen by Floyd E. Bloom, The Scripps Research Institute. Appointed by the National Research Council, he was responsible for making certain that an independent examination of this report was carried out in accordance with institutional procedures and that all review comments were carefully considered. Responsibility for the final content of this report rests entirely with the authoring committee and the institution. vii

CONTENTS BACKGROUND………………………………………………………………………………….1 Features of the 1994 National Vaccine Plan, 3 The Committee’s Approach to Reviewing the Plan, 3 CHANGES SINCE 1994…………………………………………………………………………3 PROGRESS SINCE 1994..………………………………………………………………………4 GUIDANCE FOR DEVELOPING A NEW NATIONAL VACCINE PLAN………………...8 Process Issues, 8 Content Areas, 13 CONCLUDING REMARKS…………………………………………………………………...17 APPENDIXES A References……………………………………………………………………………………..19 B Statement of Task……………………………………………………………………...............22 C Meeting One Agenda…………………………..………………………………………………23 D 1994 National Vaccine Plan Goals, Objectives, and Anticipated Outcomes…………...……..26 ix

Next: Letter Report »
Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office Get This Book
×
Buy Paperback | $21.00 Buy Ebook | $16.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

This book is the Institute of Medicine's response to the first part of the statement of task asking for a review of the 1994 National Vaccine Plan. The Committee on the Review of Priorities in the National Vaccine Plan reviewed the goals, objectives, strategies, and anticipated outcomes presented in the plan; their findings are contained in this book. In the first section of the book, the committee examines what has changed in the broader social, policy, and economic context of vaccine development and immunization, and highlights several areas where noteworthy progress has been made, particularly by federal agencies. The committee acknowledges that progress in developing and delivering vaccines has benefited from essential contributions by other stakeholders, including researchers, manufacturers, state and local public health agencies, and health care providers. In the second section of the book, the committee uses what it learned from reviewing the 1994 plan and the process of preparing it to distill key elements. Based on these elements, the committee offers guidance to NVPO and its partners on developing the update to the national vaccine plan.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  6. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  7. ×

    View our suggested citation for this chapter.

    « Back Next »
  8. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!